Related topics: influenza

Tamiflu Metabolite Found in Sewage Discharge, River Water

(PhysOrg.com) -- In a study published September 28th ahead of print in the peer-reviewed journal Environmental Health Perspectives, researchers measured oseltamivir carboxylate (OC), the active metabolite of the popular anti-influenza ...

Toward a less expensive version of the anti-flu drug Tamiflu

Scientists have developed an alternative method for producing the active ingredient in TamifluĀ®, the mainstay for fighting H1N1 and other forms of influenza. The new process could expand availability of the drug by reducing ...

How drugs get those tongue-twisting generic names

Oseltamivir. Esomeprazole. Trastuzumab. Where do drugs get those odd-sounding generic names? The answers are in the current issue of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society, ...

Oseltamivir

Oseltamivir INN ( /ɒsəlˈtæmɨvɪər/), an antiviral drug, slows the spread of influenza (flu) virus between cells in the body by stopping the virus from chemically cutting ties with its host cell; median time to symptom alleviation is reduced by 0.5–1 day. The drug is sold under the trade name Tamiflu, and is taken orally in capsules or as a suspension. It has been used to treat and prevent influenza A virus and influenza B virus infection in over 50 million people since 1999.[citation needed]

Oseltamivir is a prodrug, a (relatively) inactive chemical which is converted into its active form by metabolic process after it is taken into the body. It was the first orally active neuraminidase inhibitor commercially developed.[citation needed] It was developed by C.U. Kim, W. Lew, and X. Chen of US-based Gilead Sciences, and is currently marketed by Hoffmann–La Roche (Roche). In Japan, it is marketed by Chugai Pharmaceutical Co., which is more than 50% owned by Roche.

As of December 2010[update], the World Health Organization (WHO) reported 314 samples of the prevalent 2009 pandemic H1N1 flu tested worldwide have shown resistance to oseltamivir.

This text uses material from Wikipedia, licensed under CC BY-SA